documents: FDA-1999-D-0081-0004

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-1999-D-0081-0004 FDA FDA-1999-D-0081 Testing of Retroviral Vector-Based Human Gene Therapy Products for Replication Competent Retrovirus During Product Manufacture and Patient Follow-up; Draft Guidance for Industry; Availability Notice Notice of Availability 2018-07-12T04:00:00Z 2018 7 2018-07-12T04:00:00Z   2018-07-12T17:26:33Z 2018-14868 0 0 09000064834d7d00

Links from other tables